1. Signaling Pathways
  2. Cytoskeleton
  3. Integrin
  4. αIIbβ3 Isoform
  5. αIIbβ3 Inhibitor

αIIbβ3 Inhibitor

αIIbβ3 Inhibitor (1):

Cat. No. Product Name Effect Purity
  • HY-P99560
    Tadocizumab
    Inhibitor
    Tadocizumab (C4G1; YM-337) is a humanized monoclonal antibody tageting integrin αIIbβ3. Tadocizumab has antiplatelet and antithrombotic effects, and can be used for cardiovascular disease research.